These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 31881983)

  • 1. S100a4 upregulation in Pik3caH1047R;Trp53R270H;MMTV-Cre-driven mammary tumors promotes metastasis.
    Yuan W; Goldstein LD; Durinck S; Chen YJ; Nguyen TT; Kljavin NM; Sokol ES; Stawiski EW; Haley B; Ziai J; Modrusan Z; Seshagiri S
    Breast Cancer Res; 2019 Dec; 21(1):152. PubMed ID: 31881983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.
    Adams JR; Xu K; Liu JC; Agamez NM; Loch AJ; Wong RG; Wang W; Wright KL; Lane TF; Zacksenhaus E; Egan SE
    Cancer Res; 2011 Apr; 71(7):2706-17. PubMed ID: 21324922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
    Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
    Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors.
    Grum-Schwensen B; Klingelhöfer J; Grigorian M; Almholt K; Nielsen BS; Lukanidin E; Ambartsumian N
    Cancer Res; 2010 Feb; 70(3):936-47. PubMed ID: 20103644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors.
    Merino VF; Cho S; Liang X; Park S; Jin K; Chen Q; Pan D; Zahnow CA; Rein AR; Sukumar S
    Mol Oncol; 2017 May; 11(5):552-566. PubMed ID: 28296140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes affected by mouse mammary tumor virus (MMTV) proviral insertions in mouse mammary tumors are deregulated or mutated in primary human mammary tumors.
    Callahan R; Mudunur U; Bargo S; Raafat A; McCurdy D; Boulanger C; Lowther W; Stephens R; Luke BT; Stewart C; Wu X; Munroe D; Smith GH
    Oncotarget; 2012 Nov; 3(11):1320-34. PubMed ID: 23131872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours.
    Davies MP; Rudland PS; Robertson L; Parry EW; Jolicoeur P; Barraclough R
    Oncogene; 1996 Oct; 13(8):1631-7. PubMed ID: 8895508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21-CDK4/6-Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance.
    Cheng X; Sun Y; Highkin M; Vemalapally N; Jin X; Zhou B; Prior JL; Tipton AR; Li S; Iliuk A; Achilefu S; Hagemann IS; Edwards JR; Bose R
    Cancer Res; 2023 Sep; 83(17):2839-2857. PubMed ID: 37272756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator.
    McDaniel JM; Morrissey RL; Dibra D; Patel LR; Xiong S; Zhang Y; Chau GP; Su X; Qi Y; El-Naggar AK; Lozano G
    Cancer Res Commun; 2024 Aug; 4(8):1991-2007. PubMed ID: 38994678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer.
    Simpson PT; Shoker BS; Barraclough R; Halliwell N; Rudland PS; Sibson DR; Davies MP
    Int J Exp Pathol; 2003 Aug; 84(4):173-84. PubMed ID: 14632631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model for luminal epithelial like ER positive subtype of human breast cancer.
    Kumar MJ; Ponvijay KS; Nandhini R; Nagarajan RS; Jose J; Srinivas G; Nagarajan P; Venkatesan R; Kumar K; Singh S
    BMC Cancer; 2007 Sep; 7():180. PubMed ID: 17880731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
    Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
    Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
    Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
    Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Roles of S100A4 in Anaplastic Cells of Canine Mammary Carcinomas.
    Yoshimura H; Otsuka A; Michishita M; Yamamoto M; Ashizawa M; Zushi M; Moriya M; Azakami D; Ochiai K; Matsuda Y; Ishiwata T; Kamiya S; Takahashi K
    Vet Pathol; 2019 May; 56(3):389-398. PubMed ID: 30686112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
    Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
    Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
    BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.
    Decock J; Hendrickx W; Thirkettle S; Gutiérrez-Fernández A; Robinson SD; Edwards DR
    Breast Cancer Res; 2015 Mar; 17(1):38. PubMed ID: 25848906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.